Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen S Montine

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Journal of Alzheimer'S Disease : JAD|June 16, 2012
Anatomic and clinical pathology of cognitive impairment and dementiaKathleen S Montine, Thomas J Montine
The Journal of Experimental Medicine|May 6, 2015
Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseasesThomas J Montine, Kathleen S Montine
Journal of Neuroinflammation|April 11, 2006
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement miceIzumi Maezawa, Nobuyo Maeda, Thomas J Montine, et al.
Alzheimer'S Research & Therapy|July 5, 2011
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's diseaseJake G Hoekstra, Kathleen S Montine, Jing Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2015
Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microgliaXianwu Li, Kathleen S Montine, C Dirk Keene, et al.
Neurotoxicity Research|April 24, 2003
Dopamine thioethers: formation in brain and neurotoxicityKathleen S. Montine, Kathrin R. Sidell, Jing Zhang, et al.
Glia|May 28, 2005
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunityFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 17, 2006
Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPKIzumi Maezawa, Mary Nivison, Kathleen S Montine, et al.
Brain Pathology (Zurich, Switzerland)|May 26, 2005
Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neuronsFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 2, 2005
Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherolDejan Milatovic, Mike VanRollins, Ke Li, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal of Alzheimer'S Disease : JAD|June 16, 2012
Anatomic and clinical pathology of cognitive impairment and dementiaKathleen S Montine, Thomas J Montine
The Journal of Experimental Medicine|May 6, 2015
Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseasesThomas J Montine, Kathleen S Montine
Journal of Neuroinflammation|April 11, 2006
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement miceIzumi Maezawa, Nobuyo Maeda, Thomas J Montine, et al.
Alzheimer'S Research & Therapy|July 5, 2011
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's diseaseJake G Hoekstra, Kathleen S Montine, Jing Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2015
Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microgliaXianwu Li, Kathleen S Montine, C Dirk Keene, et al.
Neurotoxicity Research|April 24, 2003
Dopamine thioethers: formation in brain and neurotoxicityKathleen S. Montine, Kathrin R. Sidell, Jing Zhang, et al.
Glia|May 28, 2005
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunityFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 17, 2006
Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPKIzumi Maezawa, Mary Nivison, Kathleen S Montine, et al.
Brain Pathology (Zurich, Switzerland)|May 26, 2005
Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neuronsFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 2, 2005
Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherolDejan Milatovic, Mike VanRollins, Ke Li, et al.
Pageof 10